| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Invitae Corp | Chief Financial Officer | Common Stock | 241,975 | $156,800 | $0.6480 | 14 Jun 2021 | Direct |
| NGM BIOPHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 0 | 05 Apr 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024042602-guyer-shelly-d-2024-04-05 | NGM BIOPHARMACEUTICALS INC | 05 Apr 2024 | 5 | $0 | 4 | Director | 08 Apr 2024, 16:12 |
| /report/000120919123029192-guyer-shelly-d-2023-05-10 | NGM BIOPHARMACEUTICALS INC | 10 May 2023 | 1 | $0 | 4 | Director | 12 May 2023, 17:54 |
| /report/000120919122031130-guyer-shelly-d-2022-05-18 | NGM BIOPHARMACEUTICALS INC | 18 May 2022 | 1 | $0 | 4 | Director | 20 May 2022, 18:21 |
| /report/000089924321024198-guyer-shelly-d-2021-06-14 | Invitae Corp | 14 Jun 2021 | 1 | -$313,405 | 4 | Chief Financial Officer | 16 Jun 2021, 17:52 |
| /report/000120919121039589-guyer-shelly-d-2021-06-08 | NGM BIOPHARMACEUTICALS INC | 08 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 17:37 |
| /report/000089924321020279-guyer-shelly-d-2021-05-06 | Invitae Corp | 06 May 2021 | 2 | -$94,111 | 4 | Chief Financial Officer | 20 May 2021, 20:30 |